1.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: BUMC-MS-1, NCI-V88-0412
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: CUCCC-90-C01, NCI-V91-0009
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: CRC-TU-GA3004, EU-90033
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CBRG-9115, NBSG-9115, NCI-V93-0342
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-837051, NCCTG-83-70-51
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: YALE-HIC-3027, NCI-V84-0057
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: BUMC-CT-2, NCI-V88-0411
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: BUMC-8603, NCI-V86-0041
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-857051, MAYO-857051, NCCTG-85-70-51
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MCV-VCU-8707-2N, NCI-V88-0415
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: SVMC-AII/IL-2, NCI-V89-0295
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-915052, MAYO-915052, NCCTG-91-50-52
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to physiologic 75
Sponsor: Other
Protocol IDs: CDR0000064631, CBRG-9510, NBSG-9510, NCI-V96-0835, NCT00002733
|
|
14.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to physiologic 70
Sponsor: NCI
Protocol IDs: BRMP-8304, NCI-83-C-214, NCI-T84-0262N, T84-0262
|
|
15.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: DFCI-83092, NCI-T84-0194W, T84-0194
|
|
16.
|
Phase: No phase specified
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CYTOGEN-95-C-01, NCI-V97-1250
|
|
17.
|
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: PVSG-14
|
|
18.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: LCCC 0909, 10-0256, NCT01169012
|
Mobile | Español
